Cardiac Surgeon
St Michael's Hospital, University of Toronto, ON
Toronto, United States
Dr Subodh Verma is an internationally renowned cardiac surgeon-scientist and Professor at the University of Toronto. He is the current Canada Research Chair in Cardiovascular Surgery, and was recently awarded the 2021 Lister Prize in Surgery from University of Toronto in recognition of his outstanding
and continuing productivity of international stature. He is an appointee of the American Association of Thoracic Surgeons (AATS) and a member of the College of New Scholars, Artists and Scientists, Royal Society of Canada. According to Google Scholar in May 2021, Dr Verma has an h-index of 101 and his work has
been cited over 51,000 times. Dr Verma has published extensively in highly impactful journals like NEJM, Lancet, Circulation, JACC, Nature, and JCI. He is an Associate Editor of European Heart Journal. Dr Verma is an active contributor to Canadian clinical practice guidelines and co-authored the recently updated recommendations for atrial fibrillation, antiplatelet therapy, diabetes, and heart failure; he was a member of the 2018 AATS consensus guidelines committee on bicuspid aortic valve-related aortopathy. Dr Verma has served in various capacities on the American Heart Association Council on Cardiovascular
Surgery and Anesthesia since 2008. Dr Verma had/has leadership roles on 10 contemporary global heart failure trials – several of which have led to paradigm changes in how individuals who live with diabetes and heart failure are now managed. He founded and oversees the CardioLink platform at St Michael’s Hospital that is conducting cardiometabolic and surgically oriented RCTs and translational studies. Dr Verma leads a dynamic pre-clinical and translational research team that leverages pre-clinical disease models and clinical trial-derived data to identify novel mediators of cardiometabolic diseases as well as answer timely and relevant healthcare questions. His current research focus is centred around the potential of modulating vascular regenerative cell exhaustion to alleviate cardiometabolic risk.
Thursday, October 27, 2022
3:52 PM – 4:00 PM EDT
Thursday, October 27, 2022
4:35 PM – 4:43 PM EDT
Thursday, October 27, 2022
4:59 PM – 5:11 PM EDT
Thursday, October 27, 2022
5:23 PM – 5:30 PM EDT
Friday, October 28, 2022
11:00 AM – 12:00 PM EDT
Friday, October 28, 2022
2:18 PM – 2:33 PM EDT
Saturday, October 29, 2022
12:00 PM – 12:20 PM EDT
Saturday, October 29, 2022
2:00 PM – 3:00 PM EDT
Sunday, October 30, 2022
8:30 AM – 9:15 AM EDT
Sunday, October 30, 2022
9:45 AM – 10:30 AM EDT
Sunday, October 30, 2022
11:00 AM – 11:45 AM EDT